Cargando…

Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry

[Image: see text] De novo drug design with desired biological activities is crucial for developing novel therapeutics for patients. The drug development process is time- and resource-consuming, and it has a low probability of success. Recent advances in machine learning and deep learning technology...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Po-Yu, Yang, Ya-Chu, Chiang, Wei-Yin, Hsiao, Jen-Yueh, Cao, Yudong, Aliper, Alex, Ren, Feng, Aspuru-Guzik, Alán, Zhavoronkov, Alex, Hsieh, Min-Hsiu, Lin, Yen-Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268960/
https://www.ncbi.nlm.nih.gov/pubmed/37171372
http://dx.doi.org/10.1021/acs.jcim.3c00562
_version_ 1785059141231837184
author Kao, Po-Yu
Yang, Ya-Chu
Chiang, Wei-Yin
Hsiao, Jen-Yueh
Cao, Yudong
Aliper, Alex
Ren, Feng
Aspuru-Guzik, Alán
Zhavoronkov, Alex
Hsieh, Min-Hsiu
Lin, Yen-Chu
author_facet Kao, Po-Yu
Yang, Ya-Chu
Chiang, Wei-Yin
Hsiao, Jen-Yueh
Cao, Yudong
Aliper, Alex
Ren, Feng
Aspuru-Guzik, Alán
Zhavoronkov, Alex
Hsieh, Min-Hsiu
Lin, Yen-Chu
author_sort Kao, Po-Yu
collection PubMed
description [Image: see text] De novo drug design with desired biological activities is crucial for developing novel therapeutics for patients. The drug development process is time- and resource-consuming, and it has a low probability of success. Recent advances in machine learning and deep learning technology have reduced the time and cost of the discovery process and therefore, improved pharmaceutical research and development. In this paper, we explore the combination of two rapidly developing fields with lead candidate discovery in the drug development process. First, artificial intelligence has already been demonstrated to successfully accelerate conventional drug design approaches. Second, quantum computing has demonstrated promising potential in different applications, such as quantum chemistry, combinatorial optimizations, and machine learning. This article explores hybrid quantum-classical generative adversarial networks (GAN) for small molecule discovery. We substituted each element of GAN with a variational quantum circuit (VQC) and demonstrated the quantum advantages in the small drug discovery. Utilizing a VQC in the noise generator of a GAN to generate small molecules achieves better physicochemical properties and performance in the goal-directed benchmark than the classical counterpart. Moreover, we demonstrate the potential of a VQC with only tens of learnable parameters in the generator of GAN to generate small molecules. We also demonstrate the quantum advantage of a VQC in the discriminator of GAN. In this hybrid model, the number of learnable parameters is significantly less than the classical ones, and it can still generate valid molecules. The hybrid model with only tens of training parameters in the quantum discriminator outperforms the MLP-based one in terms of both generated molecule properties and the achieved KL divergence. However, the hybrid quantum-classical GANs still face challenges in generating unique and valid molecules compared to their classical counterparts.
format Online
Article
Text
id pubmed-10268960
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-102689602023-06-16 Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry Kao, Po-Yu Yang, Ya-Chu Chiang, Wei-Yin Hsiao, Jen-Yueh Cao, Yudong Aliper, Alex Ren, Feng Aspuru-Guzik, Alán Zhavoronkov, Alex Hsieh, Min-Hsiu Lin, Yen-Chu J Chem Inf Model [Image: see text] De novo drug design with desired biological activities is crucial for developing novel therapeutics for patients. The drug development process is time- and resource-consuming, and it has a low probability of success. Recent advances in machine learning and deep learning technology have reduced the time and cost of the discovery process and therefore, improved pharmaceutical research and development. In this paper, we explore the combination of two rapidly developing fields with lead candidate discovery in the drug development process. First, artificial intelligence has already been demonstrated to successfully accelerate conventional drug design approaches. Second, quantum computing has demonstrated promising potential in different applications, such as quantum chemistry, combinatorial optimizations, and machine learning. This article explores hybrid quantum-classical generative adversarial networks (GAN) for small molecule discovery. We substituted each element of GAN with a variational quantum circuit (VQC) and demonstrated the quantum advantages in the small drug discovery. Utilizing a VQC in the noise generator of a GAN to generate small molecules achieves better physicochemical properties and performance in the goal-directed benchmark than the classical counterpart. Moreover, we demonstrate the potential of a VQC with only tens of learnable parameters in the generator of GAN to generate small molecules. We also demonstrate the quantum advantage of a VQC in the discriminator of GAN. In this hybrid model, the number of learnable parameters is significantly less than the classical ones, and it can still generate valid molecules. The hybrid model with only tens of training parameters in the quantum discriminator outperforms the MLP-based one in terms of both generated molecule properties and the achieved KL divergence. However, the hybrid quantum-classical GANs still face challenges in generating unique and valid molecules compared to their classical counterparts. American Chemical Society 2023-05-12 /pmc/articles/PMC10268960/ /pubmed/37171372 http://dx.doi.org/10.1021/acs.jcim.3c00562 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Kao, Po-Yu
Yang, Ya-Chu
Chiang, Wei-Yin
Hsiao, Jen-Yueh
Cao, Yudong
Aliper, Alex
Ren, Feng
Aspuru-Guzik, Alán
Zhavoronkov, Alex
Hsieh, Min-Hsiu
Lin, Yen-Chu
Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
title Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
title_full Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
title_fullStr Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
title_full_unstemmed Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
title_short Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
title_sort exploring the advantages of quantum generative adversarial networks in generative chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268960/
https://www.ncbi.nlm.nih.gov/pubmed/37171372
http://dx.doi.org/10.1021/acs.jcim.3c00562
work_keys_str_mv AT kaopoyu exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT yangyachu exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT chiangweiyin exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT hsiaojenyueh exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT caoyudong exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT aliperalex exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT renfeng exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT aspuruguzikalan exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT zhavoronkovalex exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT hsiehminhsiu exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry
AT linyenchu exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry